Evaluating and Extracts as Potential Adjuvant Agents in Colorectal Cancer: Insights from HT-29 and Caco-2 Models.

: Colorectal cancer (CRC) remains a major health challenge due to its high incidence and resistance to conventional therapies. Natural compounds have gained attention as potential adjuvant treatments. The study assesses whether combining and [rich in oligomeric proanthocyanidins condensed (OPCs)] extracts enhances cell viability reduction and migration inhibition.